SUPERSTRING CAPITAL MANAGEMENT LP
Position in ORIC — Oric Pharmaceuticals, Inc.
CIK 1931118
NEW YORK, NY
Position in ORIC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,397,813
+$2,937,799 QoQ
Shares Held
406,077
+252.4% QoQ
Ownership
0.392%
of shares outstanding
% of Portfolio
2.76%
of 13F equity value
Holder Rank
#51
of 179 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORIC Over Time
Shares Held
Position Value (USD)
Derivatives in ORIC
reported options exposure · as of Dec 31, 2024CallValue
$1,614,000
CallShares
200,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026SUPERSTRING CAPITAL MANAGEMENT LP holds $154,068,139 across 30 Biotechnology names. ORIC ranks #15 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
343,284 | $13,285,090 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
53,916 | $13,197,019 | |
| 3 | GMAB |
Genmab A/S
|
430,600 | $11,828,582 | |
| 4 | CLDX |
Celldex Therapeutics, Inc.
|
287,583 | $10,700,963 | |
| 5 | TRVI |
Trevi Therapeutics, Inc.
|
524,224 | $9,776,777 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
51,053 | $9,561,205 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
188,282 | $8,856,785 | |
| 8 | VIR |
Vir Biotechnology, Inc.
|
853,685 | $8,699,050 |
All Filings in ORIC
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,397,813 | 406,077 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,460,014 | 115,234 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,088,926 | 255,370 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,072,152 | 89,346 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,500,958 | 344,922 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $4,571,102 | 819,194 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,756,612 | 1,580,745 | Shares | Sole | 2025-02-14 | |
| 2024-12-31 | $1,614,000 | 200,000 | Call | Sole | 2025-02-14 | |
| 2024-09-30 | $9,732,600 | 949,522 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||